[Structural and Functional Remodeling of Vascular Wall in Persons With Family History of Hypertension].

Aim of investigation - to study parameters of structural and functional remodeling of vascular wall in persons with family history of hypertension (with burdened or positive hypertensive heredity). We examined 95 persons (aged 17 - 28 years) with family history of hypertension (positive hypertensive heredity) and divided them into 3 groups: group 1 - patients with arterial hypertension (AH), group 2 - patients with high normal blood pressure (BP), group 3 - persons with normal BP). Control (C) group comprised 24 subjects with normal BP without family history of AH.

[Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].

Aim of investigation - to study effect of angiotensin-converting enzyme (ACE) gene polymorphism as a dominant risk factor of development of chronic heart failure (CHF) and target for effective therapy with ACE inhibitor enalapril in patients with ischemic heart disease. We followed 226 patients with CHF on stable permanent basic therapy comprising -adrenoblocker, diuretic, aldosterone antagonist, digoxin, and ACE inhibitor. Seventy eight patients received enalapril (starting dose 2.

[Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure].

Aim: To study the impact of angiotensinogen (AGT) and angiotensin II receptor type 1 (AGTR1) gene polymorphisms on the development and course of chronic heart failure (CHF) in patients with coronary heart disease (CHD).

Subjects And Methods: Two hundred and twenty-six patients (149 men and 77 women; mean age 55.9 +/- 5.

[Rational minimally invasive nature in surgical reconstructions of the abdominal aorta].

Based on a meta-analysis of the literature and own experience in a total of 490 reconstructions of the aortofemoral segment using a miniapproach, the authors carried out a comparative analysis of the main minimally invasive methods employed for treatment of the pathology concerned.

[Outcomes of using autologous peripheral-blood stem cells in patients with chronic lower arterial insufficiency].

Presented herein are the outcomes of using autologous peripheral blood stem cells (SCs) in patients with stage II В lower limb chronic obliterating diseases (according to A.V. Pokrovsky's classification).